Celiac disease is a chronic autoimmune disorder where ingestion of gluten—found in wheat, barley, and rye—causes the immune system to damage the lining of the small intestine. This condition affects both children and adults, leading to symptoms such as abdominal pain, bloating, diarrhea, and fatigue. Without proper management, it can lead to serious complications like malnutrition, osteoporosis, and even infertility.
As the awareness for celiac disease increases, timely and accurate diagnosis has become essential. However, traditional methods of diagnosis often fall short, requiring more precise and dependable testing to conrm the condition and monitor its progression. This is where YHLO’s CLIA (iFlash) system plays a transformative role, offering an exclusive diagnostic parameter for celiac disease.
Celiac Disease Diagnostics: The Demand for Accurate Testing
Celiac disease is extremely difcult to diagnose due to its varied symptoms, which often overlap with other conditions. Early and accurate diagnosis is crucial to avoid long-term complications and to help patients adopt a gluten-free diet, the only effective treatment. Current diagnostic methods often include serological tests for specic antibodies associated with celiac disease.
Om Surgical offers the CLIA (iFlash) system, which provides a reliable and comprehensive testing solution to detect key celiac disease markers. This system is equipped with the capability to test for multiple essential parameters, ensuring accurate diagnosis and ongoing monitoring of the disease.
From Symptoms to Solutions: YHLO CLIA (iFlash) for Celiac Disease
The YHLO CLIA (iFlash) System offers an inclusive diagnostic solution for celiac disease by utilising chemiluminescence immunoassay (CLIA) technology for clear-cut results. Available in three models-iFlash 1200, iFlash 1800, iFlash 3000 and iFlash 9000-it accommodates varying test volumes and facility requirements. Key markers include: tTG IgA: A primary diagnostic marker for celiac disease, indicating gluten-induced intestinal damage.
tTG IgG: Essential for diagnosing celiac disease in IgA-decient individuals. DGP IgA: Sensitive for early detection and mild symptoms of celiac disease. DGP IgG: Detects gluten-induced damage in patients with low IgA levels.
Solutions for Disorders Associated with Celiac Disease
In addition to Celiac disease testing, the iFlash system also offers solutions for diagnosing and managing disorders commonly associated with CD, including: Anaemia: Ferritin, Folate, Vitamin B12 Bone Metabolism: 25-OH Vitamin D, PTH Autoimmune Diabetes: IA-2A, IAA, GADA, ICA, ZnT8A Autoimmunity: Useful in managing T1DM, thyroid disease, and autoimmune liver diseases Thyroid Disorders: TSH, Anti-TPO, Anti-TSHR, Anti-Tg
Why Choose CLIA (iFlash) for Celiac Disease Testing?
Om Surgical is committed to bringing advanced diagnostic tools to Nepal to enhance patient care. The iFlash system offers several key benets for healthcare providers: High Sensitivity and Specicity: Advanced chemiluminescence technology ensures precise detection of celiac biomarkers, reducing false positives and negatives. Broad Range of Parameters: Covers essential markers—tTG IgA, tTG IgG, DGP IgA, and DGP IgG—to address diverse diagnostic needs, including cases with IgA deciency. Adaptable Throughput: Modular design caters to low, medium, and high workloads, ensuring cost-effectiveness without compromising quality. User-Friendly Interface: Streamlined software ensures instinctive operation, reducing training time and increasing lab efciency.
Conclusion
As the prevalence of celiac disease continues to rise globally, the demand for accurate and reliable diagnostic solutions has become increasingly critical. Proper diagnosis and management are essential to improving patient outcomes, particularly in Nepal, where healthcare providers face unique challenges in addressing autoimmune disorders.
With its reliability, versatility, and ability to streamline complex diagnostic processes, the iFlash system sets a new standard for autoimmune disorder management. Om Surgical is proud to bring this diagnostic platform to Nepal, bridging the gap between evolving healthcare needs and innovative solutions.
